Abstract
Background: Kasa is the outcome due to release of obstructed Vayu resulting in the production of abnormal sound, which may be productive or dry. Kasa is one of the primary diseases of Pranavaha srotas, and can cause disturbances in other body functions. Prevalence of cough in India is 5% to 10% while acute cases of cough is 39% and chronic cases of cough is 29% reported in Maharashtra. This research drug is taken to check its efficacy on both the types of cough, dry as well as productive with acute or chronic origin. It has a good palatability and liked by children as it appears as candy. Many studies have been carried out on Kasa with different formulations so far like vati, churna, ghrita but they have no fast and long lasting action with different level of efficacy. Many lozenges are also available in the market but no studies have been done.
 Objective: Comparative Study on the efficacy of Kantakari lozenges with Vasa lozenges in the clinical features of Kasa by subjective criteria such as Peenasa-(running nose), Kasa, Aruchi-(taste impliedness), kanthkandu(throat itching), kaphnishthivan (Sputum) and objective criteria as adventitious sound and AEC-absolute eosinophil count, TLC-total leucocytes count, and DLC-differential leucocyte count.
 Materials and Methods: The present study is designed as a Double Blind, Randomized Controlled Study in which total 60 patients will be enrolled. Patients will be randomly divided (by computer generated sequence method) in two with 30 patients in each group. In group A, Vasa lozenges and in group B Kantkari lozenges will be given for 7 days. Assessment of the patients will be done on 3rd and 7th day during study after intervention and post treatment follow up will be taken on 14th& 21st day from the enrolled date.
 Results: Efficacy of both the lozenges will be observed in subjective and objective outcomes. Conclusion: Kantkari lozenges (trial group) is expected to be more effective than Vasa lozenges (control group) in the management of Kasa as Vata, Kapha are more dominant in the pathology of Kasa in children and Kantakari is a good Vatakaphahar drug added with Pippali to act synergistically.
Highlights
Acharya Charaka has defined Kasa as release of obstructed Vayu resulting in the production of abnormal sound in the process, which may be productive or dry [1]
The expected result of this study is that Group K with Kantkari lozenges will be more effective as compared to Group V with Vasa lozenges
It will effective in relieving the symptoms of Kasa like Peenasa, Kasa, Aruchi, kanthkandu, kaphnishthivan owing to its opposite action from Samprapti of Kasa
Summary
Acharya Charaka has defined Kasa as release of obstructed Vayu resulting in the production of abnormal sound in the process, which may be productive or dry [1]. Cough is one of the most common symptoms in children [4,5] and the common cause for which parents are seeking relief for their children [6] In maximum children, acute cough pharyngitis is because of viral upper respiratory tract infection (URTI) [7] It is one of the most common viral infections [8,9] because of unhealthy lifestyle, food habits, polluted air and low immunity having the symptoms like dry cough or with bouts of sputam, common cold or coryza is communal disease in today’s era. This research drug is taken to check its efficacy on both the types of cough, dry as well as productive with acute or chronic origin It has a good palatability and liked by children as it appears as candy. Many lozenges are available in the market but no studies have been done
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
